News BioLife Solutions, Inc.

Equities

BLFS

US09062W2044

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-17 pm EDT			5-day change	1st Jan Change
15.14 ^USD	-5.38%		-12.28%	-6.83%

Apr. 04	Jefferies Initiates Coverage on BioLife Solutions With Buy Rating, $22 Price Target	MT
Feb. 29	BioLife Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Initiates Coverage on BioLife Solutions With Buy Rating, $22 Price Target	Apr. 04	MT
BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences	Mar. 04	PR
BioLife Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Transcript : BioLife Solutions, Inc., Q4 2023 Earnings Call, Feb 29, 2024	Feb. 29
BioLife Solutions, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results	Feb. 29	PR
BioLife Solutions to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update on February 29, 2024	Feb. 20	PR
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue	Jan. 08	PR
Biolife Solutions Announces Preliminary Unaudited Revenue Results for Fourth Quarter and Full Year 2023	Jan. 08	CI
Lake Street Adjusts BioLife Solutions Price Target to $15 From $25, Maintains Buy Rating	Nov. 10	MT
Transcript : BioLife Solutions, Inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
BioLife Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
BioLife Solutions Reports Third Quarter 2023 Financial Results	Nov. 09	PR
BioLife Solutions to Provide Third Quarter 2023 Financial Results and Business Update on November 9, 2023	Nov. 02	PR
Casdin Capital Engages in Discussions with BioLife Solutions	23-10-24	CI
BioLife Solutions Names New CEO; Sees 2023 Revenue at Low End of Guidance	23-10-19	MT
BioLife Solutions, Inc. Announces Chief Executive Officer Changes	23-10-19	CI
BioLife Solutions, Inc. Announces Management Changes	23-10-19	CI
BioLife Solutions, Inc. Revises Earnings Guidance for the Full Year 2023	23-10-19	CI
BioLife Solutions, Inc. announced that it has received $10.374976 million in funding from Casdin Capital, LLC	23-10-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News BioLife Solutions, Inc.

Equities

BLFS

US09062W2044

Summary

Filters